Brief: Oncozenge Enters Licensing Agreement With Avernus Pharma
11/04/2025 09:27
April 11 (Reuters) - Oncozenge AB ONCOZ.ST: ONCOZENGE ENTERS LICENSING AGREEMENT WITH AVERNUS PHARMA FOR BUPIZENGE IN THE GCC REGION Source text: ID:nWkr6FxWbw Further company coverage: ONCOZ.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))